Tumor cells release fragments of their DNA into the circulation, so called cell‐free tumor
DNA (ctDNA), allowing for analysis of tumor DNA in a simple blood test, that is, liquid biopsy …

Infectious diseases pose serious threats to public health worldwide. Conventional diagnostic
methods for infectious diseases often exhibit low sensitivity, invasiveness, and long …

Abstract Purpose: Human papillomavirus (HPV) DNA offers a convenient circulating tumor
DNA (ctDNA) marker for HPV-associated malignancies, but current methods, such as digital …

The rapid, low-cost and user-friendly methods for nucleic acid detection is urgently needed.
Here we developed a miniaturized and convenient photoelectrochemical biosensor array …

Background There is an alarming increase in human papillomavirus‐associated head and
neck cancer (HNC), reaching epidemic levels. While patient prognosis is generally good, off …

Human papilloma virus (HPV) is an infectious carcinogenic agent. Nearly all cervical
cancers are positive for one of the high-risk HPV subtypes. Although the introduction of the …

Human papillomavirus (HPV)-associated cancers, including oropharyngeal squamous cell
carcinoma (HPV+ OPSCC), cervical cancer, and squamous cell carcinoma of the anus …

Human papillomavirus (HPV) circulating tumor DNA (HPV ctDNA) was proposed as a
biomarker for the detection and disease monitoring of HPV-related cancers. One hundred …

Human papillomavirus (HPV) infections are the primary cause of almost all cervical cancers,
anal cancers, and a variable proportion of other anogenital tumors, as well as head and …

For cervical cancer (CC), circulating cell‐free HPV DNA (ccfHPV) may establish disease
severity. Furthermore, HPV integration has been correlated to viral load and survival. In this …